Large-scale testing (Phase 3)WithdrawnNCT01593527
What this trial is testing
Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease
Who this might be right for
Acute Gouty Arthritis
Novartis Pharmaceuticals